---
title: "Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials 3443683"
ocid: "ocds-h6vhtk-02a618"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a618"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a618.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a618.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "PROCUREMENT AND LOGISTICS SERVICE"
published: "2021-07-28"
---

# Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials 3443683

Buyer: PROCUREMENT AND LOGISTICS SERVICE  
Current stage: Award  
OCID: ocds-h6vhtk-02a618

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a618)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02a618.json)

## Summary

The procurement process involves the purchase of Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials by the Procurement and Logistics Service, covering the health sector in the UK. The procurement procedure is classified as an open tender, which allows a wide range of suppliers to participate. The tender is currently active and runs until the submission deadline on 18th May 2021. The framework agreement is anticipated to commence on 7th September 2021, lasting for an initial term of two years, with options for extension for up to 24 months.

This tender presents significant opportunities for businesses engaged in the production and distribution of medical equipment and pharmaceuticals, particularly small and medium-sized enterprises (SMEs) looking to expand their market presence. Companies that specialise in radiopharmaceuticals or related medical supplies would be well-suited to bid for this contract, as it covers multiple lots with varying financial values, collectively reaching over £11.6 million for the overall procurement.

## Notice

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials

### Lot Information

Lot 1: Ioflupane I-123

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a CentralPurchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 2: MIBG I-123 metaiodobenzylguanidine

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 3: Sodium Iodide I-123

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 4: Sodium Iodide Therapy Capsule I-131

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 5: Sodium Iodide Liquid I-131

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 6: Therapeutic MIBG I-131 metaiodobenzylguanidine

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 7: Gallium Citrate Ga-67

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. TheClient may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 8: Generator Krypton Gas Kr-81

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 9: Generator Technetium Mo-99/Tc-99m

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 10: Samarium Sm-153

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 11: Selenium Homocholic Acid Taurine/Tauroselcholic Acid Se-75

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 12: Radium Dichloride Ra-223

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 13: Indium DTPA In-111 Diethylenetriamine Pentaacetate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 14: OCTREOSCAN 122MBQ IN111 OCTREOTIDE

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 15: DMSA Dimercaptosuccinic Acid

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 16: DTPA Diethylenetriamine Pentaacetate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 17: Exametazime

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 18: HDP Hydroxymethylene Diphosphonate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 19: Human Albumin Nanocolloid

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 20: MAA Macro Aggregated Albumin

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 21: Mertiatide

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 22: Mebrofenin

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 23: MIBI Sestamibi - Methoxyisobutylisonitrile

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 24: Sodium Pyrophosphate

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 25: Tetrofosmin

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 26: Tin Colloid

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 27 - Tektrotyd

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 28 - Diphosphono-Propanedicarbosylic Acid DPD

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 29 - Sirspheres

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 30 - Lutathera

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

Lot 31- Yttrium Silicate Y-90

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

LOT 32 - Sterile Nitrogen Vials

Radiopharmaceutical Products, Generators and Sterile Nitrogen Vials. Additional information: In section 1.2, it is stated that this procurement is a joint procedure and contract award is by a Central Purchasing Body. This contract is not a joint contract, it is a Central Purchasing Body Contract operated by BSO PaLS on behalf of the participants listed in section 1.1.

Options: It is anticipated that this Framework Agreement will commence on 7th Sept 2021 for a duration of 2 years. The Client may at any time before the completion of the contract period invite the Contractor to agree to extend for any period up to and including 24 months commencing from the termination date of the original contract period.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/017942-2021 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Jul 2021 |
| Submission deadline | 18 May 2021 |
| Future notice date | Not specified |
| Award date | 27 Jul 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £11,607,952 |
| Lots value | £11,607,967 |
| Awards value | Not specified |
| Contracts value | £6,323,226 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active, Unsuccessful |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | PROCUREMENT AND LOGISTICS SERVICE |
| Additional buyers | BELFAST HEALTH AND SOCIAL CARE TRUST; WESTERN HEALTH AND SOCIAL CARE TRUST |
| Locality | LONDONDERRY |
| Post town | Northern Ireland |
| Postcode | BT47 6YZ |
| Country | Northern Ireland |
| ITL 1 | TLN Northern Ireland |
| ITL 2 | TLN0 Northern Ireland |
| ITL 3 | TLN0A Derry City and Strabane |
| Local authority | Derry City and Strabane |
| Electoral ward | Kilfennan |
| Westminster constituency | Foyle |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 4 |
| Supplier names | BAYER; CURIUM PHARMA; GE HEALTHCARE; XIEL |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33000000 - Medical equipments, pharmaceuticals and personal care products
- 33151400 - Radiotherapy supplies
- 33600000 - Pharmaceutical products

## Release History

- 28 Jul 2021 at 13:45 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/017942-2021
- 14 Apr 2021 at 15:55 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/007847-2021

## Notice URLs

- https://etendersni.gov.uk/epps

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a618. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02a618.json.